Efficacy of Chemotherapy in BRCA1/2 Mutation Carrier Ovarian Cancer in the Setting of PARP Inhibitor Resistance: A Multi-Institutional Study

✍ Scribed by Ang, Joo Ern (author);Gourley, Charlie (author);Powell, C. Bethan (author);High, Hilda (author);Shapira-Frommer, Ronnie (author);Castonguay, Vincent (author);De Greve, Jacques (author);Atkinson, Tina (author);Yap, Timothy A. (author);Sandhu, Shahneen (author);Banerjee, Susana (author);Chen, Lee May (author);Friedlander, Michael L. (author);Kaufman, Bella (author);Oza, Amit M. (author);Matulonis, Ursula (author);Barber, Louise J. (author);Kozarewa, Iwanka (author);Fenwick, Kerry (author);Assiotis, Ioannis (author);Campbell, James (author);Chen, Lina (author);De Bono, Johann S. (author);Gore, Martin E. (author);Lord, Christopher J. (author);Ashworth, Alan (author);Kaye, Stan B. (author)

• Book ID: 121392882
• Publisher: American Association for Cancer Research
• Year: 2013
• Tongue: English
• Weight: 230 KB
• Volume: 19
• Category: Article
• ISSN: 1078-0432
• DOI: 10.1158/1078-0432.CCR-13-1262